SCHEMBL17294167

SCHEMBL17294167

O=C1NC(=O)C(NO)(c2ccccc2)C(=O)N1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP9 P14780 7/20 0.52
▸ MMP2 P08253 6/20 0.52
▸ CYP2C9 P11712 2/20 0.47
▸ CACNA1F O60840 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HTR2A P28223 1/20 0.47
▸ HRH1 P35367 1/20 0.47
▸ SCN1A P35498 1/20 0.47
▸ SCN4A P35499 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ PMP22 Q01453 1/20 0.47
▸ CACNA1D Q01668 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ CACNA1S Q13698 1/20 0.47
▸ CACNA1C Q13936 1/20 0.47
▸ SCN5A Q14524 1/20 0.47
▸ SCN2A Q99250 1/20 0.47
▸ SCN3A Q9NY46 1/20 0.47
▸ MMP8 P22894 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17294195 0.85 LMNA (0.38) MMP9MMP2CYP2C9CACNA1FALDH1A1
SCHEMBL17294181 0.85 MAPT (0.41) MMP9MMP2CYP2C9CACNA1FALDH1A1
SCHEMBL7482004 0.77 ALDH1A1 (0.46) MMP9MMP2CYP2C9CACNA1FALDH1A1
SCHEMBL7480050 0.74 HDAC2 (0.50) MMP9MMP2CYP2C9ALDH1A1MAPT
SCHEMBL7480044 0.74 HDAC2 (0.50) MMP9MMP2CYP2C9ALDH1A1MAPT
SCHEMBL7469234 0.74 SMN1; SMN2 (0.48) MMP9MMP2ALDH1A1MAPTBLM
SCHEMBL11042592 0.72 MMP9 (0.57) MMP9MMP2CYP2C9CACNA1FALDH1A1
SCHEMBL7480698 0.72 AKR1B1 (0.48) MMP9MMP2ALDH1A1MAPTBLM
SCHEMBL7343875 0.72 POLB (0.44) MMP9MMP2CYP2C9CACNA1FALDH1A1
SCHEMBL17290225 0.72 BACE1 (0.37) MMP9MMP2CYP2C9CACNA1FALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148983-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS The Johns Hopkins University (US) 2017-04-05 — — EP claimed
US-9464061-B2 N-hydroxylamino-barbituric acid derivatives THE JOHNS HOPKINS UNIVERSITY (US) 2016-10-11 — — US claimed
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES NATIONAL SCIENCE FOUNDATION 2016-03-03 — — US claimed
WO-2015183838-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY (US) 2015-12-03 — — WO claimed
EP-3148983-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS The Johns Hopkins University (US) 2017-04-05 — — EP disclosed
US-9464061-B2 N-hydroxylamino-barbituric acid derivatives THE JOHNS HOPKINS UNIVERSITY (US) 2016-10-11 — — US disclosed
US-9464061-B2 N-hydroxylamino-barbituric acid derivatives THE JOHNS HOPKINS UNIVERSITY (US) 2016-10-11 — — US disclosed
US-9464061-B2 N-hydroxylamino-barbituric acid derivatives THE JOHNS HOPKINS UNIVERSITY (US) 2016-10-11 — — US disclosed
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES NATIONAL SCIENCE FOUNDATION 2016-03-03 — — US disclosed
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES NATIONAL SCIENCE FOUNDATION 2016-03-03 — — US disclosed
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES NATIONAL SCIENCE FOUNDATION 2016-03-03 — — US disclosed
WO-2015183838-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY (US) 2015-12-03 — — WO disclosed
WO-2015183838-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY (US) 2015-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES TNNT2, TNNI3, TNNC1 MMP9 3542/4885MMP2 3465/4885CYP2C9 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback